Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
LOC100506790 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANTXR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DOCK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSPAN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
RARB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UG0898H09 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MEGF6 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR61 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TTLL11 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM108 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPFIA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AFF4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC101927305 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EDAR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAP2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HMCN1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FUT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on